B

Biohaven Ltd
D

BHVN

45.630
USD
0.47
(1.04%)
Market Open
Volume
9,566
EPS
-9
Div Yield
-
P/E
-5
Market Cap
4,614,208,085
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    AGIO
    -1.645
    (-2.97%)
    53.810 USD
    A
    ALKS
    -0.150
    (-0.53%)
    28.200 USD
    A
    ALLO
    -0.19000
    (-7.71%)
    2.27500 USD
    B
    BPMC
    -6.990
    (-7.31%)
    88.690 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    I
    ICPT
    0
    (0%)
    0.000000 USD
    R
    RGNX
    -1.51500
    (-13.60%)
    9.62500 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.93 USD
    More
News

Title: Biohaven Ltd

Sector: Healthcare
Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.